Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna S Tocheva

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Current Allergy and Asthma Reports|September 29, 2017
Checkpoint Inhibitors: Applications for AutoimmunityAnna S Tocheva, Adam Mor
Current Protocols in Immunology|August 7, 2020
In Vitro Assays to Study PD-1 Biology in Human T CellsAnna S Tocheva, Shalom Lerrer, Adam Mor
Immunology|June 24, 2021
PD-1-induced proliferating T cells exhibit a distinct transcriptional signatureMarianne Strazza, Shoiab Bukhari, Anna S Tocheva, et al.
Plos One|February 11, 2021
A novel mouse model for checkpoint inhibitor-induced adverse eventsKieran Adam, Alina Iuga, Anna S Tocheva, et al.
Immunology Letters|March 20, 2021
VRK2 inhibition synergizes with PD-1 blockade to improve T cell responsesMichael Peled, Anna S Tocheva, Kieran Adam, et al.
Iscience|September 15, 2021
PD-1-stimulated T cell subsets are transcriptionally and functionally distinctShalom Lerrer, Anna S Tocheva, Shoiab Bukhari, et al.
Plos One|June 15, 2019
SLAMF6 clustering is required to augment T cell activationMatthew A Dragovich, Kieran Adam, Marianne Strazza, et al.
Vaccine|May 18, 2013
Distribution of carried pneumococcal clones in UK children following the introduction of the 7-valent pneumococcal conjugate vaccine: a 3-year cross-sectional population based analysisAnna S Tocheva, Johanna M C Jefferies, M Christodoulides, et al.
Emerging Infectious Diseases|December 25, 2009
Increase in serotype 6C pneumococcal carriage, United KingdomAnna S Tocheva, Johanna M C Jefferies, Myron Christodoulides, et al.
The Journal of Infectious Diseases|January 2, 2010
Induction of type 2 responses by schistosome worms during prepatent infectionLucia Alves de Oliveira Fraga, Marina N Torrero, Anna S Tocheva, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Current Allergy and Asthma Reports|September 29, 2017
Checkpoint Inhibitors: Applications for AutoimmunityAnna S Tocheva, Adam Mor
Current Protocols in Immunology|August 7, 2020
In Vitro Assays to Study PD-1 Biology in Human T CellsAnna S Tocheva, Shalom Lerrer, Adam Mor
Immunology|June 24, 2021
PD-1-induced proliferating T cells exhibit a distinct transcriptional signatureMarianne Strazza, Shoiab Bukhari, Anna S Tocheva, et al.
Plos One|February 11, 2021
A novel mouse model for checkpoint inhibitor-induced adverse eventsKieran Adam, Alina Iuga, Anna S Tocheva, et al.
Immunology Letters|March 20, 2021
VRK2 inhibition synergizes with PD-1 blockade to improve T cell responsesMichael Peled, Anna S Tocheva, Kieran Adam, et al.
Iscience|September 15, 2021
PD-1-stimulated T cell subsets are transcriptionally and functionally distinctShalom Lerrer, Anna S Tocheva, Shoiab Bukhari, et al.
Plos One|June 15, 2019
SLAMF6 clustering is required to augment T cell activationMatthew A Dragovich, Kieran Adam, Marianne Strazza, et al.
Vaccine|May 18, 2013
Distribution of carried pneumococcal clones in UK children following the introduction of the 7-valent pneumococcal conjugate vaccine: a 3-year cross-sectional population based analysisAnna S Tocheva, Johanna M C Jefferies, M Christodoulides, et al.
Emerging Infectious Diseases|December 25, 2009
Increase in serotype 6C pneumococcal carriage, United KingdomAnna S Tocheva, Johanna M C Jefferies, Myron Christodoulides, et al.
The Journal of Infectious Diseases|January 2, 2010
Induction of type 2 responses by schistosome worms during prepatent infectionLucia Alves de Oliveira Fraga, Marina N Torrero, Anna S Tocheva, et al.
Pageof 3